DRUG DEVELOPMENT

Microneedle patch drug delivery in the gut

Article metrics

A novel oral capsule can deploy microneedle patches that release drugs into the intestinal wall for uptake into the bloodstream as shown in animal studies, thereby avoiding injections.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Oral capsule for delivery of biologics via the intestine using microneedle patches.

References

  1. 1.

    Marcum, Z. A., Sevick, M. A. & Handler, S. M. JAMA 309, 2105–2106 (2013).

  2. 2.

    Rubin, R. R., Peyrot, M., Kruger, D. F. & Travis, L. B. Diabetes Educ. 35, 1014–1022 (2009).

  3. 3.

    Liu, C., Kou, Y., Zhang, X., Cheng, H., Chen, X. & Mao, S. Expert Opin. Drug Deliv. 15, 223–233 (2018).

  4. 4.

    Abramson, A. et al. Nat. Med. https://doi.org/10.1038/s41591-019-0598-9 (2019).

  5. 5.

    Homayun, B., Lin, X. T. & Choi, H. J. Pharmaceutics 11(3), 129 (2019).

  6. 6.

    Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Adv. Drug Deliv. Rev. 23, 3–25 (1997).

  7. 7.

    Prausnitz, M. R. Annu. Rev. Chem. Biomol. 8, 177–200 (1997).

  8. 8.

    Bhatnagar, S., Dave, K. & Venuganti, V. V. K. J. Control. Release 260, 164–182 (2017).

  9. 9.

    Hou, A., Cohen, B., Haimovic, A. & Elbuluk, N. Dermatol. Surg. 43, 321–339 (2017).

  10. 10.

    Grover, N. Endpoints News https://endpts.com/robotic-pill-technology-found-to-be-safe-tolerable-in-early-human-study-paving-ground-for-oral-biologics/ (28 February 2019).

Download references

Author information

Correspondence to Mark R. Prausnitz.

Ethics declarations

Competing interests

M.P. is an inventor of patents that have been or may be licensed to companies developing microneedle-based products, is a paid advisor to companies developing microneedle-based products and is a founder/shareholder of companies developing microneedle-based products, including Micron Biomedical. These potential conflicts of interest have been disclosed and are being managed by Georgia Tech and/or Emory University.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark